64 related articles for article (PubMed ID: 29984794)
1. A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?
Persoon AC; Jager PL; Sluiter WJ; Plukker JT; Wolffenbuttel BH; Links TP
PLoS One; 2007 Aug; 2(8):e816. PubMed ID: 17726546
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Serum Thyroglobulin Level as a Useful Predictive Marker to Differentiate Thyroid Cancer.
Kars A; Aktan B; Kilic K; Sakat MS; Gözeler MS; Yörük Ö; Mutlu V; Yılmaz S
ORL J Otorhinolaryngol Relat Spec; 2018; 80(5-6):290-295. PubMed ID: 30253396
[TBL] [Abstract][Full Text] [Related]
3. Does it work in childhood and adolescence? The predictive role of postoperative/preablative stimulated thyroglobulin levels in paediatric thyroid cancer. A systematic review of the literature.
Piccardo A; Fiz F; Bottoni G; Foppiani L; Albano D; Bertagna F; Catrambone U; Mariani F; Sambucco B; Massollo M; Treglia G; Trimboli P
Rev Endocr Metab Disord; 2024 Feb; 25(1):53-63. PubMed ID: 37743443
[TBL] [Abstract][Full Text] [Related]
4. Impact of Thyroglobulin and Thyroglobulin Antibody Assay Performance on the Differential Classification of DTC Patients.
Schoonen L; Neele M; van Toor H; van Kinschot CMJ; van Noord C; Visser WE; Groen J; Boesten LSM; Lentjes EGWM; van den Berg SAA; Kos S
J Endocr Soc; 2022 Jan; 6(1):bvab166. PubMed ID: 35024538
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series.
Giovanella L; Milan L; Roll W; Weber M; Schenke S; Kreissl M; Vrachimis A; Pabst K; Murat T; Petranović Ovčariček P; Campenni A; Görges R; Ceriani L
Clin Chem Lab Med; 2024 May; ():. PubMed ID: 38706105
[TBL] [Abstract][Full Text] [Related]
6. Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas.
Warda F; Ho S; Kuo E; Rao D; Jurado-Flores M
Case Rep Endocrinol; 2022; 2022():5355419. PubMed ID: 35096430
[TBL] [Abstract][Full Text] [Related]
7. Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial.
Jammah AA; Masood A; Akkielah LA; Alhaddad S; Alhaddad MA; Alharbi M; Alguwaihes A; Alzahrani S
Front Endocrinol (Lausanne); 2020; 11():603432. PubMed ID: 33716951
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.
Viana AOR; Gonçalves Filho J; Francisco ALN; Pinto CAL; Kowalski LP
Acta Otorhinolaryngol Ital; 2020 Jun; 40(3):190-197. PubMed ID: 32773780
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
10. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of an ultrasensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer: can the stimulation test be avoided in patients with an intermediate recurrence risk?
Flores-Rebollar A; Pérez-Díaz I; Lagunas-Bárcenas S; García-Martínez B; Rivera-Moscoso R; Fagundo-Sierra R
Acta Otorhinolaryngol Ital; 2018 Jun; 38(3):188-193. PubMed ID: 29984794
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
13. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
[TBL] [Abstract][Full Text] [Related]
14. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
[TBL] [Abstract][Full Text] [Related]
15. The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma.
Castagna MG; Tala Jury HP; Cipri C; Belardini V; Fioravanti C; Pasqui L; Sestini F; Theodoropoulou A; Pacini F
J Endocrinol Invest; 2011 Sep; 34(8):e219-23. PubMed ID: 21399390
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
